Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-90,000
Closed -$2.72M 771
2022
Q3
$2.72M Sell
90,000
-10,000
-10% -$366K 0.03% 469
2022
Q2
$3.48M Buy
100,000
+50,000
+100% +$1.97M 0.04% 436
2022
Q1
$2.6M Hold
50,000
0.03% 475
2021
Q4
$2.51M Buy
50,000
+35,000
+233% +$2.28M 0.02% 516
2021
Q3
$1.21M Buy
15,000
+5,000
+50% +$366K 0.01% 595
2021
Q2
$582K Buy
+10,000
New +$561K 0.01% 603

Other funds holding DOCS

UBS O'Connor's DOCS Position: Q4 2022 in Review

UBS O'Connor sold out of Doximity (DOCS) in Q4 2022, closing a stake of 90,000 shares — an estimated $2.72M sold.

UBS O'Connor first reported a position in DOCS in Q2 2021 and held it in 6 quarters. The position peaked at $3.48M in Q2 2022. 303 funds tracked by Wall St. Rank hold DOCS as of Q4 2022.

  • UBS O'Connor reported no remaining Doximity position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 90,000 Doximity shares in Q4 2022, an estimated $2.72M.
  • UBS O'Connor first reported a position in Doximity in Q2 2021 and held it in 6 quarters.
  • UBS O'Connor's Doximity position peaked at $3.48M in Q2 2022.
  • 303 funds tracked by Wall St. Rank held Doximity as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.